ScottR.VandenbergMD

Pathology • San Francisco, CA

Neuropathology, Anatomic Pathology, Clinical Pathology

Professor, Pathology, UCSD School of Medicine

Join to view full profile

Dr. Vandenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vandenberg's full profile

Already have an account?

Office
513 Parnassus Ave
San Francisco, CA 94143
Phone+1 415-502-7796

Fax+1 415-476-1963

Education & Training

University of Virginia Medical CenterResidency, Pathology-Anatomic and Clinical, 1982 - 1984
Stanford Health Care-Sponsored Stanford UniversityFellowship, Neuropathology, 1980 - 1982
University of Colorado School of MedicineInternship, Transitional Year, 1979 - 1980
Stanford University School of MedicineClass of 1979

Certifications & Licensure

CA State Medical License 1980 - 2026
VA State Medical License 1981 - 2004

Publications & Presentations

PubMed

80 citations
Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240
Tim R. Fenton, David Nathanson, Claudio P. Albuquerque, Daisuke Kuga, Akio Iwanami
Proceedings of the National Academy of Sciences of the United States of America. 2012-08-28
5682 citations
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Roger E. McLendon, Allan H. Friedman, Darrell D. Bigner, Erwin G. Van Meir, Daniel J. Brat
Nature. 2008-10-23
125 citations
Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma
John K. Wiencke, Shichun Zheng, Nanette Jelluma, Tarik Tihan, Scott R. VandenBerg
Neuro-Oncology. 2007-07-01

Press Mentions

UCSF Names First-Ever Chief Biobank OfficerJune 17th, 2019
Bortezomib-Induced Muscle Toxicity in Multiple MyelomaJune 19th, 2017
$85 Million Grant Supports UCSF Clinical and Translational Science InstituteAugust 9th, 2016
Join now to see all

Grant Support

Tissue CoreNational Cancer Institute2007–2011